NSE: SRF | BSE: 503806

Expensive Performer

Download real time

2897.40 17.10 (0.59%)

38.69% Gain from 52W Low

350.5K NSE+BSE Volume

NSE 28 May, 2025 3:31 PM (IST)

85,886.1

Market Cap

Market Runner Up

0.9

Beta 1Year

Low volatility

SRF Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for SRF, BSE:503806 SRF Ltd.

Search Inside the pdf :

SRF Ltd.

14 May 2025

2897.40

0.59%

Amid challenges, company guides for 20% growth in chemical business

Hold: SRF Ltd.

Target

ICICI Securities Limited

SRF’s chemical business has surprised positively in Q4FY25 with a strong show in specialty chemicals and ref-gas; also, SRF is upbeat on demand outlook/orderbook for FY26. Ref-gas revenue should benefit from higher production with commissioning of AHF plant which was a bottleneck in FY25.

SRF Ltd. has gained 26.16% in the last 6 Months

SRF Ltd.

13 May 2025

2897.40

0.59%

Chemicals segment resilient and continues to grow

Buy: SRF Ltd.

Target

Motilal Oswal

SRF posted a strong overall performance in 4QFY25, with its EBIT rising 53% YoY, led by a 3.2x/50% YoY surge in packaging film/chemical businesses.

SRF Ltd. is trading below its 30 day SMA of 2965.7

SRF Ltd.

24 Mar 2025

2897.40

0.59%

SRF LTD

Accumulate: SRF Ltd.

Geojit BNP Paribas

Number of FII/FPI investors increased from 598 to 643 in Mar 2025 qtr.

SRF Ltd.

28 Feb 2025, 12:00AM

2897.40

0.59%

Chemical business to lead growth; Maintain Buy

Buy: SRF Ltd.

Target

Sharekhan

SRF’s fluorochemicals division shows strong demand with firm pricing. The company is investing Rs. 1,100 crore in less-polluting HFO (fourth generation) for FY28 launch.

SRF Ltd. is trading below its 30 day SMA of 2965.7

SRF Ltd.

26 Feb 2025

2897.40

0.59%

Medium term outlook remains strong; re-iterate BUY

Buy: SRF Ltd.

Target

Emkay

We re-iterate BUY on SRF with revised SoTP-based TP of Rs3,250 (rollover to Mar-27E; up by 4.8%), as we believe the worst is behind for all businesses of SRF and, going forward, we should see gradual pick up in specialty chemicals driven by stabilization of existing products and incremental contribution from newer products (largely Active Ingredients).

SRF Ltd. has gained 26.16% in the last 6 Months

SRF Ltd.

03 Feb 2025

2897.40

0.59%

SRF Ltd | Q3FY25 Result Update

Buy: SRF Ltd.

Target

Edelweiss

Recovery seen the chemicals business

SRF Ltd. has gained 26.16% in the last 6 Months

SRF Ltd.

31 Jan 2025

2897.40

0.59%

Worst is behind; upgrade to BUY

Buy: SRF Ltd.

Emkay

We upgrade SRF to BUY from Add and raise our SoTP-based TP by over 19% to Rs3,100, as we believe i) the worst is behind for all of its businesses, ii) SRF is seeing gradual uptick in its specialty chemical business from existing products, and healthy contribution is expected from new AIs in FY26

SRF Ltd. is trading above its 200 day SMA of 2594.4

SRF Ltd.

30 Jan 2025

2897.40

0.59%

Outlook improves for the Chemicals business

Buy: SRF Ltd.

Recommendation Target

Motilal Oswal

SRF posted a decent overall performance in 3QFY25. However, the Chemicals business and the Packaging Films business displayed material improvement during the quarter.

SRF Ltd. has an average target of 3100.86 from 9 brokers.

SRF Ltd.

25 Oct 2024

2897.40

0.59%

BP Equities Q2FY25 Result Update SRF Ltd

Results Update: SRF Ltd.

BP Wealth

SRF Ltd. has gained 26.16% in the last 6 Months

SRF Ltd.

24 Oct 2024

2897.40

0.59%

Weak print; but order book visibility healthy for H2FY25

Hold: SRF Ltd.

Target

ICICI Securities Limited

SRF’s chemicals business is facing multiple headwinds from increased Chinese competition, weak demand from agro-chemical innovators, delay in new product commercialisation and drop in prices.

SRF Ltd. is trading above its 200 day SMA of 2594.4

Is SRF Ltd. worth buying?

418 Votes:

Buy 74.64%

Sell 15.55%

Hold 9.81%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf